Ioannis K Zervantonakis Selected Research

Ioannis K Zervantonakis Research Topics

22	Neoplasms (Cancer) 03/2024 - 02/2011
8	Breast Neoplasms (Breast Cancer) 03/2024 - 11/2012
4	Ovarian Neoplasms (Ovarian Cancer) 11/2019 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2016
2	Hypoxia (Hypoxemia) 01/2017 - 11/2012
1	Hematologic Neoplasms (Hematological Malignancy) 03/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022
1	Carcinogenesis 01/2021
1	Melanoma (Melanoma, Malignant) 01/2020
1	Ovarian Epithelial Carcinoma 03/2017
1	Brain Neoplasms (Brain Tumor) 01/2016
1	Fibrosarcoma 08/2012

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2017
2	CytokinesIBA 01/2022 - 10/2021
2	Lapatinib (GW572016)FDA Link 01/2021 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2020
2	HydrogelsIBA 02/2013 - 01/2013
1	Estrogen ReceptorsIBA 03/2024
1	RNA (Ribonucleic Acid)IBA 03/2024
1	AntigensIBA 03/2024
1	Chimeric Antigen ReceptorsIBA 03/2024
1	p38 Mitogen-Activated Protein KinasesIBA 03/2022
1	Myosin Type IIIBA 03/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Coloring Agents (Dyes)IBA 01/2021
1	IntegrinsIBA 01/2021
1	VaccinesIBA 01/2020
1	Drug CombinationsIBA 01/2020
1	EpitopesIBA 01/2020
1	Apoptosis Regulatory ProteinsIBA 11/2019
1	PlatinumIBA 11/2019
1	taxaneIBA 11/2019
1	navitoclaxIBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	cobimetinibIBA 01/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2018
1	cadherin 5IBA 01/2017
1	pertuzumabIBA 01/2016
1	Matrix Metalloproteinases (MMPs)IBA 01/2016
1	AntibodiesIBA 01/2016
1	Trastuzumab (Herceptin)FDA Link 01/2016
1	Biocompatible Materials (Biomaterials)IBA 10/2014
1	Dextrans (Dextran)FDA Link 01/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012

11	Therapeutics 03/2024 - 02/2013
6	Drug Therapy (Chemotherapy) 01/2023 - 01/2016
4	Lab-On-A-Chip Devices 01/2017 - 02/2011
2	Immunotherapy 03/2024 - 01/2020
1	Combination Drug Therapy (Combination Chemotherapy) 11/2019